Q2 2026 13F · SEC CIK 1781002

Bleichroeder LP

Hedge fundFiled 2026-08-13 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value: $558.9M
Reported positions: 78
Top holdings a year, 3 yrs: +15.0%
Assets under management: $2.4B

Bleichroeder LP is a hedge fund that reported 78 positions worth $558.9M in its Q2 2026 13F, filed 2026-08-13. Its largest holdings were Spdr Gold Tr (GLD, 31.3%), Gpgi Inc (CMPO, 11.3%), State Str Spdr S&p 500 ETF T (SPY, 9.0%). A portfolio copying its top holdings returned 15.0% a year over the last 3 years, against 20.4% for the S&P 500.

Bleichroeder LP holdings largest 50 of 78 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Bleichroeder LP 13F holdings
Stock	% of 13F value	Q1 2026	Shares	Share change	Reported value
GLDSpdr Gold Tr	31.3%	35.3%	475,000	+0.0%	$175.0M
CMPOGpgi Inc	11.3%	11.7%	3,972,176	+0.1%	$63.0M
SPYState Str Spdr S&p 500 ETF T	9.0%	7.6%	67,645	+0.0%	$50.5M
RHLDResolute Hldgs Mgmt Inc	8.1%	8.8%	314,166	+0.0%	$45.4M
LINLinde PLC	5.6%	5.9%	60,434	-11.7%	$31.4M
DUOTDuos Technologies Group Inc	3.5%	1.9%	1,627,806	+0.0%	$19.5M
DTILPrecision Biosciences Inc	2.8%	1.6%	2,018,190	+21.4%	$15.9M
CUECue Biopharma Inc	2.1%	—	370,682	—	$11.7M
BXBlackstone Inc	1.9%	1.8%	90,750	+0.0%	$10.7M
IMMXImmix Biopharma Inc	1.8%	1.6%	1,000,000	+0.0%	$10.3M
IDNIntellicheck Inc	1.5%	2.5%	2,056,343	-0.8%	$8.4M
SPGIS&p Global Inc	1.5%	1.5%	20,000	+0.0%	$8.1M
INVEInve Technologies Inc	1.3%	1.8%	2,884,495	+0.0%	$7.3M
LIQTLiqtech Intl Inc	1.0%	1.1%	6,882,239	+116.3%	$5.8M
KZIAKazia Therapeutics Ltd	1.0%	0.5%	400,000	+0.0%	$5.6M
COCHEnvoy Medical Inc	0.9%	0.7%	6,250,000	+0.0%	$5.0M
CGEMCullinan Therapeutics Inc	0.8%	0.2%	250,000	+150.0%	$4.6M
WELLWelltower Inc	0.8%	0.7%	20,000	+0.0%	$4.5M
EYPTEyepoint Pharmaceuticals Inc	0.8%	0.7%	316,515	+0.0%	$4.5M
FLNTFluent Inc	0.8%	0.8%	1,142,857	-20.0%	$4.3M
GNLXGenelux Corporation	0.7%	0.6%	1,380,666	+0.0%	$4.2M
PROKProkidney Corp	0.7%	0.6%	2,000,000	+0.0%	$4.1M
COGTCogent Biosciences Inc	0.7%	—	100,000	—	$3.9M
QQQInvesco Qqq Tr	0.6%	0.5%	4,640	+0.0%	$3.4M
JPMJpmorgan Chase & Co	0.6%	0.8%	10,200	-32.0%	$3.3M
MDXHMdxhealth SA	0.5%	2.9%	7,378,333	+0.0%	$3.0M
IRDOpus Genetics Inc	0.5%	0.6%	736,842	+0.0%	$3.0M
TVGrupo Televisa S.a.b	0.5%	0.5%	1,030,000	+0.0%	$2.8M
BRFHBarfresh Food Group Inc	0.5%	0.7%	1,390,758	+0.0%	$2.8M
DMACDiamedica Therapeutics Inc	0.5%	0.4%	382,317	+0.0%	$2.7M
ROCRank One Computing Corp	0.5%	0.6%	500,000	+0.0%	$2.6M
SPIRSpire Global Inc	0.4%	—	135,000	—	$2.5M
IPWRIdeal Pwr Inc	0.4%	0.1%	400,000	+33.3%	$2.1M
NMTCNeuroone Med Technologies Co	0.4%	—	666,666	—	$2.0M
CRISCuris Inc	0.4%	0.4%	3,802,329	+0.0%	$2.0M
RVMDWRevolution Medicines Inc	0.3%	—	200,000	—	$1.9M
PROFProfound Med Corp	0.3%	0.3%	254,753	+0.0%	$1.7M
RNXTRenovorx Inc	0.3%	0.3%	1,666,098	+0.0%	$1.6M
MODDModular Med Inc	0.3%	0.2%	336,986	+80.2%	$1.5M
VENUVenu Hldg Corp	0.2%	0.3%	600,000	+0.0%	$1.4M
TLPHTalphera Inc	0.2%	0.2%	1,307,787	+0.0%	$1.3M
QTIQt Imaging Hldgs Inc	0.2%	0.2%	316,667	+90.0%	$1.3M
LLYVKLiberty Live Holdings Inc	0.2%	0.2%	13,802	+0.0%	$1.2M
DETXLiberty Defense Hldgs Ltd	0.2%	—	277,777	—	$1.1M
RNTXRein Therapeutics Inc	0.2%	—	1,000,000	—	$1.0M
OWLTOwlet Inc	0.2%	0.2%	172,000	+0.0%	$987K
SINTSintx Technologies Inc	0.2%	—	523,013	—	$978K
CLRBCellectar Biosciences Inc	0.1%	—	288,679	—	$803K
MAIAMaia Biotechnology Inc	0.1%	0.1%	500,000	+0.0%	$720K
FEAM5e Advanced Materials Inc	0.1%	0.1%	458,774	-8.2%	$638K

What Bleichroeder LP bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year: +14.2% /yr; S&P 500 +20.1%
3 years: +15.0% /yr; S&P 500 +20.4%
5 years: +3.9% /yr; S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter	13F value	Positions
Q2 2026	$558.9M	78
Q1 2026	$578.6M	81
Q4 2025	$568.3M	73
Q3 2025	$513.0M	72
Q2 2025	$406.8M	76
Q1 2025	$375.3M	78
Q4 2024	$397.9M	74
Q3 2024	$371.6M	73
Q2 2024	$336.2M	75
Q1 2024	$400.9M	80
Q4 2023	$450.0M	77
Q3 2023	$405.8M	74

Questions about Bleichroeder LP's portfolio

What stocks does Bleichroeder LP own?

Bleichroeder LP's latest 13F, for Q2 2026 and filed Aug 13, 2026, lists 78 positions worth $558.9M. The largest are Spdr Gold Tr (GLD) at 31.3%, Gpgi Inc (CMPO) at 11.3%, State Str Spdr S&p 500 ETF T (SPY) at 9.0%, Resolute Hldgs Mgmt Inc (RHLD) at 8.1% and Linde PLC (LIN) at 5.6%.

What did Bleichroeder LP buy last quarter?

In Q2 2026, Bleichroeder LP added Cullinan Therapeutics Inc (CGEM) (+150.0% shares), Liqtech Intl Inc (LIQT) (+116.3% shares) and Qt Imaging Hldgs Inc (QTI) (+90.0% shares), compared with its Q1 2026 filing.

What did Bleichroeder LP sell last quarter?

In Q2 2026, Bleichroeder LP cut from its top 50 Neuroone Med Technologies Co (NMTC), cut from its top 50 Cue Biopharma Inc (CUE), cut from its top 50 Precision Optics Corp Inc Ma (POCI), cut from its top 50 Rtx Corporation (RTX), cut from its top 50 Pixelworks Inc (PXLW), Jpmorgan Chase & Co (JPM) (-32.0% shares), Fluent Inc (FLNT) (-20.0% shares) and Linde PLC (LIN) (-11.7% shares), compared with its Q1 2026 filing.

How has Bleichroeder LP's portfolio performed?

A portfolio copying Bleichroeder LP's 20 largest 13F holdings each quarter, from the day each filing was public, returned +15.0% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +14.2% against +20.1%. Over 5 years: +3.9% a year against +11.6%.

When is Bleichroeder LP's next 13F filing due?

13F filings are due 45 days after each quarter ends. Bleichroeder LP's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Bleichroeder LP manage?

Bleichroeder LP reported $2.4B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $558.9M.